Where blood meets imaging. A new standard for early detection.
Oatmeal Health partners with biotech and liquid biopsy companies to combine blood based molecular testing with our AI powered imaging analysis, giving life sciences companies, diagnostics innovators, and clinical researchers access to the patients and infrastructure they need to validate and deliver precision medicine at scale.
Talk to our partnerships teamA blood test tells you cancer is there. Imaging tells you where it is.
Lung cancer screening today relies on low dose CT scans alone. By partnering with biotech companies that specialize in liquid biopsy, we add molecular signals from the blood that catch cancer biology early, while our AI powered imaging pinpoints exactly where. Together they reduce false positives, catch cancers earlier, and enable truly personalized risk stratification.
Liquid Biopsy (Biotech Partners)
Our biotech partners run blood based tests that detect cell free DNA fragments, methylation patterns, and tumor signals in the bloodstream. These molecular markers reveal whether cancer biology is present, often before symptoms appear.
AI Powered Imaging (Oatmeal Health)
Our CADx AI analyzes LDCT scans to assess nodule shape, density, texture, and growth patterns with radiomics. The spatial detail tells clinicians where the concern is, how large, and how it compares to known malignancy profiles.
Combined Precision Score
Fusing our biotech partners' molecular signals from blood with Oatmeal's spatial signals from imaging produces a single, higher confidence risk score. Research shows this combined approach can push specificity above 92% and significantly reduce unnecessary biopsies and follow up scans.
The infrastructure that takes years to build, ready now
Building community site relationships, earning credentialing, and deploying AI to find and reach patients typically takes sponsors years and millions of dollars. We have already done it.
Nationwide FQHC Partner Network
Established partnerships with Federally Qualified Health Centers across the country, serving 34M+ patients. Credentialed and ready for activation.
- Rural, suburban, and urban sites across multiple states
- Credentialed at partner sites, minimal setup
- Expanding network with new sites added continuously
AI Powered Patient Identification
Our AI parses EHR data across structured and unstructured fields to find every patient who meets your protocol criteria, scored by risk, reachability, and eligibility confidence.
- 0.96 AUROC risk and eligibility model
- Epic, Athena, and other major EHR integrations
- Customizable to your inclusion and exclusion criteria
Verified Diverse Patient Populations
Our patient base reflects the communities that clinical research has historically excluded. We have the demographic data and the community trust to enroll patients typically hardest to reach.
- 60%+ racial and ethnic minority patients
- Bilingual outreach in English and Spanish
- Verified demographic reporting for FDA DAP
AI Powered Patient Engagement
Our AI agents reach eligible patients through text and conversational messaging, trained on your specific therapeutic area. They educate, answer questions, and schedule visits at scale in multiple languages.
- AI agents trained on your protocol and therapeutic focus
- Bilingual text based outreach at unlimited scale
- Real time enrollment dashboard and reporting
One network. Every use case your program needs.
Whether you are enrolling a pivotal trial, validating a liquid biopsy diagnostic, building real world evidence, or meeting FDA diversity requirements, Oatmeal Health connects you to the community patient populations that make the difference.
Clinical Trial Recruitment
Most trials underenroll patients from low income and minority communities, not because they do not qualify, but because no one has reached them. Our FQHC network changes that. AI eligibility screening against your protocol criteria, bilingual outreach, and credentialed sites ready from day one.
Liquid Biopsy + AI Imaging Validation
Biotech partners bring blood based tests, we bring the AI imaging and patient infrastructure. Together we validate combined detection models against real world, diverse patient cohorts at community health sites. We provide the patient volume, the imaging pipeline, and the longitudinal data needed to prove that molecular plus spatial approaches work outside of academic centers.
Post Approval and Outcomes Studies
Generate longitudinal EHR and screening outcomes data from the populations who actually use your therapy. Our network produces real world evidence from diverse communities with HIPAA compliant data sharing and BAA ready infrastructure.
FDA Diversity Requirements
The FDA Diversity Action Plan requirements are not going away. More than 60% of our patients come from racial and ethnic minority communities, with verified demographic documentation for regulatory submissions. African American, Hispanic/Latino, Asian, and Native American patients.
From protocol to enrolled patient in weeks, not years
We handle the infrastructure. You focus on the science.
We scope the program together
We start with a call to understand your protocol, enrollment targets, diversity requirements, and timeline. Our team maps your inclusion and exclusion criteria against our patient network to give you a realistic enrollment estimate before you commit to anything.
We configure our AI and activate sites
Our AI is configured to your specific eligibility criteria and run against EHR data at our partner sites. We identify and rank every patient who qualifies, then activate outreach through the appropriate channels in the patient's preferred language.
We enroll, track, and report in real time
Consented patients are scheduled for screening, baseline visits, or study procedures depending on your protocol. Our dashboard gives you real time enrollment numbers, demographic breakdowns, and site level performance. We handle reminders, rescheduling, and retention support throughout the study period.
Let's talk about your program
Tell us about your trial, study, or validation program and we will tell you exactly what enrollment from our network looks like. No commitment required to get a feasibility assessment.
Prefer a direct conversation? Email hello@oatmealhealth.com
We respond within one business day.